CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to GILD

anitocabtagene-autoleucel

Phase 2
Gilead Sciences, Inc. (GILD)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Dec '26
GILDPhase 2

anitocabtagene-autoleucel Phase 2 Est. Readout

anitocabtagene-autoleucel
Dec 2026~
CT.gov
00%
Drug Information

Target Indication

Multiple Myeloma

Clinical Trial

NCT05396885

Last updated: 2/6/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.